Budesonide/formoterol fumarate dihydrate versus budesonide with a novel suspension technology for uncontrolled asthma: phase 3 LITHOS study.

Papi A, Wise RA, Jackson DJ, Lugogo N, Chen R, Chami H, Armengol C, Daoud SZ, Nauclér E, Bowen K, Megally A, Sobande O, Patel M

Open source

DOI: 10.1183/23120541.01818-2025
Published: 2026 Sep
Container: ERJ open research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/23120541.01818-2025,
  title = {Budesonide/formoterol fumarate dihydrate versus budesonide with a novel suspension technology for uncontrolled asthma: phase 3 LITHOS study.},
  author = {Papi A and Wise RA and Jackson DJ and Lugogo N and Chen R and Chami H and Armengol C and Daoud SZ and Nauclér E and Bowen K and Megally A and Sobande O and Patel M},
  year = {2026},
  journal = {ERJ open research},
  doi = {10.1183/23120541.01818-2025},
  url = {https://doi.org/10.1183/23120541.01818-2025}
}

RIS

TY  - JOUR
TI  - Budesonide/formoterol fumarate dihydrate versus budesonide with a novel suspension technology for uncontrolled asthma: phase 3 LITHOS study.
AU  - Papi A
AU  - Wise RA
AU  - Jackson DJ
AU  - Lugogo N
AU  - Chen R
AU  - Chami H
AU  - Armengol C
AU  - Daoud SZ
AU  - Nauclér E
AU  - Bowen K
AU  - Megally A
AU  - Sobande O
AU  - Patel M
PY  - 2026
JO  - ERJ open research
DO  - 10.1183/23120541.01818-2025
UR  - https://doi.org/10.1183/23120541.01818-2025
ER  -

APA

A, P., RA, W., DJ, J., N, L., R, C., H, C., C, A., SZ, D., E, N., K, B., A, M., O, S., & M, P. (2026). Budesonide/formoterol fumarate dihydrate versus budesonide with a novel suspension technology for uncontrolled asthma: phase 3 LITHOS study.. ERJ open research. https://doi.org/10.1183/23120541.01818-2025

Source records

pubmed · retrieved 2026-09-25T23:54:40.999Z